Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Motor Activity 15Neoplasms 11Breast Neoplasms 11Prostatic Neoplasms 7Obesity 5Head and Neck Neoplasms 5Colorectal Neoplasms 4Signs and Symptoms 3Sarcopenia 3Polycystic Ovary Syndrome 3Lung Neoplasms 3Diabetes Mellitus, Type 2 3Uterine Cervical Neoplasms 2Pharyngeal Neoplasms 2Osteoporosis, Postmenopausal 2Osteoporosis 2Lymphoma 2Leukemia 2Laryngeal Neoplasms 2Fatigue 2Diabetes Mellitus 2Weight Loss 1Uterine Neoplasms 1Urinary Incontinence 1Stroke 1Squamous Cell Carcinoma of Head and Neck 1Sedentary Behavior 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma 1

Interventions

Cytarabine 272Cyclophosphamide 136fludarabine phosphate 127Azacitidine 117Peripheral Blood Stem Cell Transplantation 95Busulfan 93Filgrastim 80Decitabine 79fludarabine 78Mycophenolic Acid 78Idarubicin 76Etoposide 76Whole-Body Irradiation 75Daunorubicin 72Tacrolimus 71Cyclosporine 64Methotrexate 62Mitoxantrone 57Clofarabine 55Antilymphocyte Serum 55Granulocyte Colony-Stimulating Factor 51Gemtuzumab 50Melphalan 49venetoclax 48Radiotherapy 30sargramostim 28Injections 25Bortezomib 25thymoglobulin 24aldesleukin 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Myeloid, Acute × Resistance Training × Clear all
NCT01170598 2012-04-20

Acute Myeloid Leukaemia (AML) Patients Undergoing Induction Chemotherapy

Toronto Rehabilitation Institute

Phase 2 Completed
35 enrolled 15 charts
Other hematologic neoplasm

Motor Activity, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡